| 1st Aug 2019 2:10 pm |
RNS |
Total Voting Rights |
| 1st Aug 2019 7:00 am |
RNS |
GSK completes transaction with Pfizer for New JV |
| 30th Jul 2019 3:35 pm |
RNS |
Director/PDMR Shareholding |
| 29th Jul 2019 7:00 am |
RNS |
ViiV submits cabotegravir to EMA for HIV injection |
| 24th Jul 2019 6:01 pm |
RNS |
Director/PDMR Shareholding |
| 24th Jul 2019 4:01 pm |
RNS |
ViiV 2DR TANGO switch study positive at 48 weeks |
| 24th Jul 2019 4:00 pm |
RNS |
ViiV GEMINI studies show high efficacy at 96 weeks |
| 24th Jul 2019 12:07 pm |
RNS |
Second Price Monitoring Extn |
| 24th Jul 2019 12:02 pm |
RNS |
Price Monitoring Extension |
| 24th Jul 2019 12:00 pm |
RNS |
2nd Quarter Results |
| 24th Jul 2019 10:00 am |
RNS |
Non-Executive Chairman |
| 22nd Jul 2019 5:00 pm |
RNS |
ViiV presents 96-week data from phase III study |
| 15th Jul 2019 6:19 pm |
RNS |
Director/PDMR Shareholding |
| 15th Jul 2019 6:18 pm |
RNS |
Director/PDMR Shareholding |
| 15th Jul 2019 6:16 pm |
RNS |
Director/PDMR Shareholding |
| 15th Jul 2019 11:42 am |
RNS |
Director/PDMR Shareholding |
| 15th Jul 2019 7:00 am |
RNS |
positive results in Phase 3 PRIMA study of ZEJULA |
| 12th Jul 2019 4:35 pm |
RNS |
Director/PDMR Shareholding |
| 12th Jul 2019 3:55 pm |
RNS |
Director/PDMR Shareholding |
| 10th Jul 2019 3:48 pm |
RNS |
Director/PDMR Shareholding |
| 10th Jul 2019 7:00 am |
RNS |
ViiV switch study shows 2DR as effective as 3DR |
| 1st Jul 2019 12:08 pm |
RNS |
Total Voting Rights |
| 12th Jun 2019 5:10 pm |
RNS |
Director/PDMR Shareholding |
| 7th Jun 2019 7:00 am |
RNS |
FDA approval for Nucala self-administration |
| 4th Jun 2019 8:00 am |
RNS |
CHMP positive on GSK's Nucala self-administration |
| 3rd Jun 2019 2:31 pm |
RNS |
Total Voting Rights |
| 24th May 2019 10:54 am |
RNS |
Director/PDMR Shareholding |
| 20th May 2019 1:44 pm |
RNS |
Director/PDMR Shareholding |
| 13th May 2019 5:44 pm |
RNS |
Block listing Interim Review |
| 13th May 2019 4:19 pm |
RNS |
Director/PDMR Shareholding |
| 8th May 2019 6:23 pm |
RNS |
Result of AGM & GM |
| 2nd May 2019 5:07 pm |
RNS |
Trelegy Ellipta asthma study met primary endpoint |
| 1st May 2019 3:11 pm |
RNS |
Director/PDMR Shareholding |
| 1st May 2019 2:32 pm |
RNS |
Total Voting Rights |
| 1st May 2019 12:00 pm |
RNS |
1st Quarter Results |
| 29th Apr 2019 12:00 pm |
RNS |
ViiV submits NDA for HIV monthly 2 drug injectable |
| 26th Apr 2019 4:16 pm |
RNS |
ViiV receives CHMP Positive Opinion for Dovato |
| 16th Apr 2019 5:36 pm |
RNS |
Director/PDMR Shareholding |
| 16th Apr 2019 5:35 pm |
RNS |
Director/PDMR Shareholding |
| 16th Apr 2019 5:23 pm |
RNS |
Director/PDMR Shareholding |
